Related Experiment Video
Updated: Jan 25, 2026

Cutaneous Surgical Denervation: A Method for Testing the Requirement for Nerves in Mouse Models of Skin Disease
Published on: June 26, 2016
Skin Directed Therapy in Cutaneous T-Cell Lymphoma
Erica S Tarabadkar1, Michi M Shinohara1
1Division of Dermatology, University of Washington, Seattle, WA, United States.
Skin directed therapies (SDTs) are crucial for treating cutaneous T-cell lymphoma (CTCL)/mycosis fungoides (MF). Topical treatments, phototherapy, and radiation therapy offer effective management options for all stages of MF, improving patient quality of life.
Area of Science:
- Dermatology
- Oncology
Background:
- Cutaneous T-cell lymphoma (CTCL), also known as mycosis fungoides (MF), is a type of non-Hodgkin lymphoma affecting the skin.
- Skin-directed therapies (SDTs) are vital for managing MF at all disease stages.
Purpose of the Study:
- To review the current landscape of SDTs for CTCL/MF.
- To highlight the efficacy and safety of various topical, phototherapy, and radiation-based treatment modalities.
Main Methods:
- Review of existing literature on SDTs for CTCL/MF.
- Analysis of response rates, efficacy, and safety data for different treatment types.
Main Results:
- Numerous topical therapies show high response rates, especially in early-stage MF.
- Phototherapy (UVB, PUVA) demonstrates efficacy and long-term safety.
- Radiation therapy remains a cornerstone treatment for all MF stages.
Conclusions:
- SDTs are essential for treating CTCL/MF, managing symptoms, and enhancing quality of life.
- A variety of effective SDT options are available for MF patients.
- Continued research supports the role of phototherapy and radiation in MF management.
Related Concept Videos
Gene Therapy
Chemotaxis and Direction of Cell Migration
Renewal of Skin Epidermal Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Directing Effect of Substituents: meta-Directing Groups
Group Therapy

